FemaSeed LOCAL Artificial Insemination Trial

Completed · Not applicable

Conditions studied: Infertility, Male Factor

In brief

Brief Summary: The objectives of the trial are to evaluate the safety and effectiveness of the FemaSeed Localized Directional Insemination for artificial insemination, now known as the FemaSeed Intratubal Insemination since FDA Cleared under K231730 in September 2023.

Key facts

Study ID
NCT04968847
Run by
Femasys Inc.
People needed
314
Starts
2021-07-15
Expected to finish
2024-04-30
Last updated by the study team
2024-11-08

Who can join

Age: 19 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.